Joseph L Goldstein - Net Worth and Insider Trading
Joseph L Goldstein Net Worth
The estimated net worth of Joseph L Goldstein is at least $5 Million dollars as of 2024-11-13. Joseph L Goldstein is the Director of Regeneron Pharmaceuticals Inc and owns about 6,382 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $5 Million. Details can be seen in Joseph L Goldstein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph L Goldstein has not made any transactions after 2024-01-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joseph L Goldstein
Joseph L Goldstein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph L Goldstein owns 1 companies in total, including Regeneron Pharmaceuticals Inc (REGN) .
Click here to see the complete history of Joseph L Goldstein’s form 4 insider trades.
Insider Ownership Summary of Joseph L Goldstein
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2024-01-23 | director |
Joseph L Goldstein Latest Holdings Summary
Joseph L Goldstein currently owns a total of 1 stock. Joseph L Goldstein owns 6,382 shares of Regeneron Pharmaceuticals Inc (REGN) as of January 23, 2024, with a value of $5 Million.
Latest Holdings of Joseph L Goldstein
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2024-01-23 | 6,382 | 821.00 | 5,239,622 |
Holding Weightings of Joseph L Goldstein
Joseph L Goldstein Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph L Goldstein has made a total of 15 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 2,707 shares on January 23, 2024, which brought Joseph L Goldstein around $3 Million.
Insider Trading History of Joseph L Goldstein
- 1
Joseph L Goldstein Trading Performance
Joseph L Goldstein Ownership Network
Ownership Network List of Joseph L Goldstein
Ownership Network Relation of Joseph L Goldstein
Joseph L Goldstein Owned Company Details
What does Regeneron Pharmaceuticals Inc do?
Who are the key executives at Regeneron Pharmaceuticals Inc?
Joseph L Goldstein is the director of Regeneron Pharmaceuticals Inc. Other key executives at Regeneron Pharmaceuticals Inc include SVP Commercial Marion Mccourt , VP & Controller Christopher R. Fenimore , and EVP Research Andrew J Murphy .
Regeneron Pharmaceuticals Inc (REGN) Insider Trades Summary
Over the past 18 months, Joseph L Goldstein made no insider transaction in Regeneron Pharmaceuticals Inc (REGN). Other recent insider transactions involving Regeneron Pharmaceuticals Inc (REGN) include a net sale of 10,814 shares made by Marion Mccourt , a net sale of 1,400 shares made by Arthur F Ryan , and a net sale of 7,918 shares made by Bonnie L Bassler .
In summary, during the past 3 months, insiders sold 26,837 shares of Regeneron Pharmaceuticals Inc (REGN) in total and bought 0 shares, with a net sale of 26,837 shares. During the past 18 months, 315,919 shares of Regeneron Pharmaceuticals Inc (REGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 315,919 shares.
Regeneron Pharmaceuticals Inc (REGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regeneron Pharmaceuticals Inc Insider Transactions
Joseph L Goldstein Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph L Goldstein. You might contact Joseph L Goldstein via mailing address: Dept Of Pharmacology K5 Yuver Of Texas, 5323 Harry Hines Blvd, Dallas Tx 75390.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
